Edition:
United Kingdom

Celldex Therapeutics Inc (CLDX.OQ)

CLDX.OQ on NASDAQ Stock Exchange Global Select Market

2.97USD
11 Dec 2017
Change (% chg)

$-0.06 (-1.98%)
Prev Close
$3.03
Open
$3.04
Day's High
$3.08
Day's Low
$2.97
Volume
182,620
Avg. Vol
256,144
52-wk High
$4.07
52-wk Low
$2.20

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.25 December 12 Dec 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 1
(2) OUTPERFORM 3 3 4 4
(3) HOLD 3 3 3 3
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.29 2.29 2.25 2.25

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 5 1.61 2.11 1.00 33.86
Quarter Ending Mar-18 1 1.50 1.50 1.50 --
Year Ending Dec-17 7 10.55 11.40 9.30 14.65
Year Ending Dec-18 7 16.86 56.00 0.00 24.00
Earnings (per share)
Quarter Ending Dec-17 7 -0.25 -0.19 -0.34 -0.03
Quarter Ending Mar-18 1 -0.22 -0.22 -0.22 --
Year Ending Dec-17 7 -0.95 -0.86 -1.08 -1.14
Year Ending Dec-18 7 -0.90 -0.59 -1.09 -1.09

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 1.09 3.92 2.83 259.93
Quarter Ending Jun-17 1.05 3.83 2.78 264.98
Quarter Ending Mar-17 0.92 1.53 0.61 66.20
Quarter Ending Dec-16 1.08 1.87 0.80 74.00
Quarter Ending Sep-16 0.87 2.22 1.35 155.85
Earnings (per share)
Quarter Ending Sep-17 -0.26 -0.20 0.06 -24.53
Quarter Ending Jun-17 -0.27 -0.23 0.04 -15.72
Quarter Ending Mar-17 -0.28 -0.25 0.03 -12.28
Quarter Ending Dec-16 -0.34 -0.30 0.04 -10.63
Quarter Ending Sep-16 -0.33 -0.29 0.04 -12.41

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 1.61 1.61 1.34 1.05 33.86
Quarter Ending Mar-18 1.50 1.50 1.50 -- --
Year Ending Dec-17 10.55 10.64 10.64 7.51 14.65
Year Ending Dec-18 16.86 18.01 18.01 16.75 24.00
Earnings (per share)
Quarter Ending Dec-17 -0.25 -0.25 -0.25 -0.28 -0.03
Quarter Ending Mar-18 -0.22 -0.22 -0.25 -0.28 --
Year Ending Dec-17 -0.95 -0.95 -0.95 -1.04 -1.14
Year Ending Dec-18 -0.90 -0.90 -0.90 -0.95 -1.09

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-17 0 0 0 0
Quarter Ending Mar-18 0 0 0 0
Year Ending Dec-17 0 0 0 0
Year Ending Dec-18 0 0 0 0
Earnings
Quarter Ending Dec-17 0 0 0 0
Quarter Ending Mar-18 0 0 0 0
Year Ending Dec-17 0 0 0 0
Year Ending Dec-18 0 0 0 0